Sruti Chandra
Impact in
-
- Nanoparticle-Based Drug Delivery
-
- RNA Interference and Gene Delivery
- Advanced biosensing and bioanalysis techniques
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- Muscle Physiology and Disorders
Papers in
-
- RNA Interference and Gene Delivery 3
- Advanced biosensing and bioanalysis techniques 2
- RNA modifications and cancer 2
- Epigenetics and DNA Methylation 2
- Cancer-related gene regulation 2
-
- SARS-CoV-2 and COVID-19 Research 3
- COVID-19 Clinical Research Studies 2
- Co-authors
- Michelle Lacey (4 shared papers)Melanie Ehrlich (4 shared papers)Carl Baribault (4 shared papers)Tarun K. Mandal (3 shared papers)Anup K. Kundu (3 shared papers)Srikanta Dash (2 shared papers)David W. Powell (1 shared paper)Thomas Wiese (1 shared paper)
- Journals
- iScience (1 paper)The Journal of Immunology (1 paper)Human Molecular Genetics (1 paper)Epigenomics (1 paper)European Journal of Pharmaceutics and Biopharmaceutics (1 paper)
- Partner nations
- United StatesRussia
In The Last Decade
Sruti Chandra
9 papers receiving 228 citations
Peers
Comparison fields: 5 of 51
- Biomaterials 45
- Molecular Biology 178
- Cancer Research 29
- Infectious Diseases 29
- Genetics 22
Countries citing papers authored by Sruti Chandra
This map shows the geographic impact of Sruti Chandra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sruti Chandra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sruti Chandra more than expected).
Fields of papers citing papers by Sruti Chandra
This network shows the impact of papers produced by Sruti Chandra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sruti Chandra. The network helps show where Sruti Chandra may publish in the future.
Co-authors
The 25 scholars most cited alongside Sruti Chandra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 76 | |
| 2 | 2013 | 46 | |
| 3 | 2021 | 28 | |
| 4 | 2020 | 21 | |
| 5 | 2015 | 18 | |
| 6 | 2021 | 18 | |
| 7 | 2014 | 12 | |
| 8 | 2017 | 9 | |
| 9 | 2024 | 1 | |
| 10 | 2023 | 0 |
About Sruti Chandra
Sruti Chandra is a scholar working on Molecular Biology, Infectious Diseases, Oncology, Biomaterials and Health, having authored 10 papers that have together received 229 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (3 papers), RNA Interference and Gene Delivery (3 papers), Advanced biosensing and bioanalysis techniques (2 papers), RNA modifications and cancer (2 papers), Epigenetics and DNA Methylation (2 papers), Cancer-related gene regulation (2 papers), Nanoparticle-Based Drug Delivery (2 papers) and COVID-19 Clinical Research Studies (2 papers). The work is most often cited by research in Biomaterials (45 citations), Molecular Biology (178 citations), Cancer Research (29 citations), Infectious Diseases (29 citations) and Genetics (22 citations). Sruti Chandra has collaborated with scholars based in United States and Russia. Frequent co-authors include Michelle Lacey, Melanie Ehrlich, Carl Baribault, Tarun K. Mandal, Anup K. Kundu, Srikanta Dash, David W. Powell, Thomas Wiese, Jolyon Terragni and Sriharsa Pradhan. Their work appears in journals such as iScience, The Journal of Immunology, Human Molecular Genetics, Epigenomics and European Journal of Pharmaceutics and Biopharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.